Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erden Atilla

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Immunity|October 3, 2025
Eomesodermin<sup>+</sup> CD4<sup>+</sup> T cells are critical for curative immunotherapy outcomesPing Zhang, Françoise Haeseleer, Olivia G Waltner, et al.
Leukemia & Lymphoma|July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsArtur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
British Journal of Haematology|January 10, 2018
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patientsArtur Jurczyszyn, Jakub Radocha, Julio Davila, et al.
American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life ExperienceDemet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Immunity|October 3, 2025
Eomesodermin<sup>+</sup> CD4<sup>+</sup> T cells are critical for curative immunotherapy outcomesPing Zhang, Françoise Haeseleer, Olivia G Waltner, et al.
Leukemia & Lymphoma|July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patientsArtur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
British Journal of Haematology|January 10, 2018
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patientsArtur Jurczyszyn, Jakub Radocha, Julio Davila, et al.
American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life ExperienceDemet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, et al.
Pageof 5